Factor xi and l-citrulline modulators: MarsRecent Research Landscape
Vascular resistance and poor drug response in hyporesponders increase cardiovascular risk. This lever stabilizes nitric oxide pathways to restore endothelial function.
What technical problems is Mars addressing in Factor xi and l-citrulline modulators?
Pathological vascular tissue remodeling
(24)evidences
Impaired endothelial nitric oxide pathways and oncogenic protein signaling failures. Addressing these malfunctions restores physiological homeostasis and overcomes therapeutic resistance.
Neurodegenerative metabolic enzyme deficiency
(2)evidences
Insufficient efficacy of existing antiepileptic treatments. Improving seizure suppression reduces neurological damage and improves patient safety.
Insufficient immune system recovery
(2)evidences
Damage or permeability in the gut lining leads to systemic inflammation and pathogen entry. Restoring this barrier prevents secondary infections and chronic inflammatory responses.